Clinical, pathological, and molecular features of myelodysplasia cutis

Blood. 2022 Feb 24;139(8):1251-1253. doi: 10.1182/blood.2021013967.

Jérémie Delaleu^{1

2}, Rathana Kim³, Lin-Pierre Zhao⁴, Adèle de Masson^{1

2}, Marie-Dominique Vignon-Pennamen⁵, Charles Cassius^{1

2}, Caroline Ram-Wolff^{1

2}, Martine Bagot^{1

2}, Emmanuelle Clappier³, Lionel Adès⁴, Marie Sebert⁴, Jean-David Bouaziz^{1

2}, Pierre Fenaux³, Maxime Battistella^{2

5}

¹ Dermatology Department, Assistance Publique - Hôpitaux de Paris (APHP) Nord, Hôpital Saint Louis, Université de Paris, Paris, France.
² INSERM U976 "Human Immunology, Pathophysiology, and Immunotherapy," Paris, France.
³ Biological Hematology Laboratory, APHP Nord, Hôpital Saint Louis, Université de Paris, Paris, France.
⁴ Clinical Hematology Department, APHP Nord, Hôpital Saint Louis, Université de Paris, Paris, France; and.
⁵ Pathology Department, APHP Nord, Hôpital Saint Louis, Université de Paris, Paris, France.

No abstract available

MeSH terms